… smooth tracking. CLINICAL…

… valve is best for you, your…

This study is evaluating the long-term safety and efficacy of the Amplatzer Septal Occluder. The results below are from 1,000 patients reported in July 2011.3 This study evaluated the

™Indicates a trademark of the Abbott group of companies. ‡Indicates a third-party trademark, which is property of its respective owner. GET THE STUDY RESULTS: AMULET™ VS WATCHMAN‡ MAT-2111416

*Note: For References 1-6, data not from head to head studies. Data differences depicted between these trials may not be directly comparable, statistically significant, or clinically meaningful due

Saver JL, Carroll JD, Thaler DE, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017;377:1022-1032. doi: 10.1056/NEJMoa1610057.

PORTICO™ WITH FLEXNAV™ TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) Portico™ with FlexNav™ TAVI System's exceptional design was purposefully built to give you complete, independent control of

… aging.…

… to the PFO without an…

with the Amplatzer™ Amulet™ LAA Occluder is an atrial fibrillation treatment that completely closes the left atrial appendage (LAA) and immediately eliminates the need for blood thinners.